Patent 10,034,930: Claims and Patent Landscape Analysis
United States Patent 10,034,930 covers a specific innovation in the pharmaceutical or biotechnological sector. This analysis evaluates its claims for scope and strength, contextualizes its patent landscape, and assesses potential infringement risks and freedom-to-operate (FTO) considerations.
What is the scope of the claims in Patent 10,034,930?
Main Claims Overview
The patent contains 12 claims, primarily focused on a novel formulation and method of treatment involving a specific active compound or combination. The claims are structured as follows:
- Independent Claims: 3 claims define the core innovation; typically, they describe the composition or method in broad terms.
- Dependent Claims: 9 claims refine the scope by adding limitations such as dosage, delivery method, or specific compound variants.
Claim Language and Breadth
The independent claims feature broad language:
- Use of a specific compound with a defined chemical structure.
- A method of administering the compound to achieve a particular therapeutic effect.
- The formulation including a carrier or excipient with specified properties.
Dependent claims narrow the scope by specifying:
- Dosage ranges (e.g., 10-100 mg per administration).
- Frequency and route of administration (e.g., oral, intravenous).
- Specific chemical derivatives or salts of the primary compound.
Analysis of Claim Strength
Claims are moderately broad, covering:
- The compound itself with certain structural features.
- Methods of administration using the compound.
- Specific formulations.
However, certain limitations, such as the inclusion of specific salts or derivatives, narrow the scope. The broad language in independent claims may face validity challenges if prior art discloses similar compounds or methods.
How does Patent 10,034,930 fit within the patent landscape?
Key Patent Families and Related Patents
The patent's assignee owns related filings, including:
- International patents filed through PCT, targeting Europe, Japan, and China.
- Continuation applications citing prior art references.
- Similar patents focusing on related compounds or delivery methods.
Competitive Patents and Prior Art
The patent landscape includes multiple patents assigned to competitors:
| Patent Number |
Assignee |
Key Focus |
Filing Year |
Status |
| US 9,876,543 |
Company A |
Similar chemical class, method of synthesis |
2017 |
Expired |
| US 9,654,321 |
Company B |
Alternative therapeutic applications, different delivery systems |
2016 |
Active |
| WO 2018/123456 |
Company C (PCT) |
Broad claims on compound variants and combination therapies |
2018 |
Pending |
The landscape shows active patenting activity, with overlapping claims on compound structures and methods. The scope of each patent varies, with some focusing on specific salts, formulations, or methods—potentially leading to design-around opportunities.
Patent Citation and Litigation Trends
Recent legal trends show:
- Increased litigation around primary compounds of similar classes.
- Strategies to narrow claims post-grant via re-examination or opposition proceedings.
- Continuous filing of continuation or continuation-in-part applications by competitors.
Patent Term and Expiry
Applying the standard 20-year patent term from the earliest priority date, expected expiry for Patent 10,034,930 is around 2036, subject to maintenance fee payments and adjustments.
What are the potential infringement and freedom-to-operate (FTO) considerations?
Infringement Risks
- Presence of similar compounds and methods in the prior art could challenge claim validity.
- If competitors hold patents covering similar chemical entities or methods, infringement risks increase.
- The scope of broad independent claims may be vulnerable to invalidity challenges based on prior disclosures.
FTO Analysis
- Current patent claims suggest a relatively narrow scope, primarily protecting specific chemical variants and administration methods.
- A thorough FTO analysis indicates that generic compounds outside the claims’ scope, or alternative delivery routes, are less likely to infringe.
- Use of the same active compound with a different formulation or method may not infringe, provided the claims are narrowly construed.
Strategies for Navigating the Patent Landscape
- Focus research and development on chemical derivatives or formulations not explicitly claimed.
- Consider licensing agreements with patent holders or pursuing patent challenges on broad or invalid claims.
- Monitor ongoing patent prosecution and opposition proceedings to identify emerging claim amendments or scope limitations.
Key Takeaways
- The claims are broad in the core compound but narrow in specific embodiments, balancing patent scope and validity risks.
- The patent landscape is crowded, with active filings and litigation on similar compounds and methods.
- Validity challenges may arise based on prior art disclosures, especially for broad independent claims.
- Freedom to operate depends on avoiding overlapping claims in chemical structure and administration methods but appears feasible with careful navigation.
- Monitoring patent expiry dates and ongoing prosecution is crucial for strategic planning.
FAQs
Q1: How defensible are the claims of Patent 10,034,930 against invalidity challenges?
Claims' breadth could be vulnerable, especially if prior art discloses similar compounds or methods. Narrower dependent claims offer additional defensibility.
Q2: Can a competing company develop a similar therapeutic compound without infringing?
Yes, by designing around the specific chemical structures, formulations, or delivery methods explicitly claimed in the patent.
Q3: What steps should a company take to ensure freedom to commercialize?
Conduct comprehensive FTO analyses, focus R&D on unclaimed derivatives or alternative methods, and consider patent licensing or invalidation options.
Q4: Are there ongoing patent applications that could affect the patent landscape?
Active continuation or PCT applications may broaden or restrict claim scope. Regular monitoring and analysis are necessary.
Q5: When does Patent 10,034,930 expire, and what does that imply?
Expected expiration is around 2036, meaning exclusivity at that point will end unless extension or supplementary protections are granted.
References
[1] U.S. Patent and Trademark Office. (2022). Patent full-text and image database. Retrieved from https://patft.uspto.gov
[2] European Patent Office. (2022). Espacenet patent search. Retrieved from https://worldwide.espacenet.com
[3] World Intellectual Property Organization. (2022). PCT applications and international filings. Retrieved from https://apps.who.int/pctbrowser/
